These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1395223)

  • 1. Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin.
    Tomer Y; Shoenfeld Y
    Clin Exp Rheumatol; 1992; 10(4):391-3. PubMed ID: 1395223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
    Lazurova I; Macejova Z; Benhatchi K; Oetterová M; Antolová E; Asherson RA; Rovensky J
    Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of early secondary myelofibrosis in SLE with IVIG.
    Aharon A; Levy Y; Bar-Dayan Y; Afek A; Zandman-Goddard G; Skurnik Y; Fabrrizzi F; Shoenfeld Y
    Lupus; 1997; 6(4):408-11. PubMed ID: 9175029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics, treatments and outcome of psychosis in Thai SLE patients.
    Paholpak P; Rangseekajee P; Foocharoen C
    J Psychosom Res; 2012 Dec; 73(6):448-51. PubMed ID: 23148813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E; Kessel A; Shoenfeld Y
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin.
    Sherer Y; Levy Y; Langevitz P; Lorber M; Fabrizzi F; Shoenfeld Y
    Clin Rheumatol; 1999; 18(2):170-3. PubMed ID: 10357127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus.
    Sherer Y; Levy Y; Shoenfeld Y
    Clin Rheumatol; 1999; 18(3):238-40. PubMed ID: 11206350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
    Zandman-Goddard G; Levy Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature.
    Milstone AM; Meyers K; Elia J
    Clin Rheumatol; 2005 Aug; 24(4):394-7. PubMed ID: 15662488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis.
    Meissner M; Sherer Y; Levy Y; Chwalinska-Sadowska H; Langevitz P; Shoenfeld Y
    Rheumatol Int; 2000; 19(5):199-201. PubMed ID: 10984139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
    Migliaresi S; Gallo M; Tirri G
    Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report.
    Su JA; Wu CH; Tsang HY
    Gen Hosp Psychiatry; 2007; 29(1):75-7. PubMed ID: 17189752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
    Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
    Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.
    Racz Z; Nagy E; Rosivall L; Szebeni J; Hamar P
    Lupus; 2010 Apr; 19(5):599-612. PubMed ID: 20167630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of acute psychosis in children with Systemic Lupus Erythematosus (SLE): consultation-liaison service experiences at a tertiary-care pediatric institution.
    Muscal E; Nadeem T; Li X; Mian A; Harris TB
    Psychosomatics; 2010; 51(6):508-14. PubMed ID: 21051683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.